Keros Therapeutics rises after adoption of 'poison pill' plan, review of strategic options

Keros Therapeutics

10/04/2025 11:21

** Shares of drug developer Keros Therapeutics KROS.O rise 17.4% to $12.09 premarket

** KROS says its board had authorized a stockholder rights plan, also known as a "poison pill", in response to the rapid accumulation of co's stock by some investors

** Co also launches a process to evaluate strategic alternatives, including a possible sale

** Up to last close, shares have fallen 34.7% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))